CHEMICAL CHAPERONE EFFECTS ON ARGININE-VASOPRESSIN RECEPTOR 2 MUTANTS
- 5 January 2022
- journal article
- Published by Hacettepe University in Hacettepe Journal of Biology and Chemistry
- Vol. 50 (1), 37-43
- https://doi.org/10.15671/hjbc.669854
Abstract
Improper folding of the mutant proteins may finally cause several conformational diseases such as Nephrogenic Diabetes Insipidus (NDI). In recent years, as a therapeutic strategy, chaperone treatment for such diseases is among current issues. In our study, we aimed to analyze the effect of several chemical chaperones on mutant V2 receptors which cause NDI. V2R mutant constructs were introduced into the pLV2R. Mutants were transiently expressed in COS-7 cells. After MTT analyses, cell surface ELISA experiment was performed for understanding the rescue potential of the chaperones of the mutated proteins. As a result, we analyzed that rescue potential of a chemical chaperone depends on both chemical compound and the mutation type. We may conclude that such chaperone treatment studies are valuable for development of the therapeutic strategies.Keywords
This publication has 21 references indexed in Scilit:
- A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish familyEndocrine, 2013
- Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperonesNephrology, 2007
- Protein Misfolding and Human DiseaseAnnual Review of Genomics and Human Genetics, 2006
- Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidusAmerican Journal of Physiology-Renal Physiology, 2006
- Rescue of Vasopressin V2 Receptor Mutants by Chemical Chaperones: Specificity and MechanismMolecular Biology of the Cell, 2006
- Pharmacological chaperones: potential treatment for conformational diseasesTrends in Endocrinology & Metabolism, 2004
- Chemical Chaperones Regulate Molecular Chaperones in Vitro and in Cells under Combined Salt and Heat StressesOnline Journal of Public Health Informatics, 2001
- Manipulating the Amyloid-β Aggregation Pathway with Chemical ChaperonesOnline Journal of Public Health Informatics, 1999
- 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V2ReceptorsJournal of Medicinal Chemistry, 1998
- Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis MutationOnline Journal of Public Health Informatics, 1996